Dr. Bhatt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Rw-563
Boston, MA 02215Phone+1 617-667-5288
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2002 - 2006- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2002
Weill Cornell MedicineClass of 2000
Certifications & Licensure
MA State Medical License 2002 - 2025
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma Start of enrollment: 2007 Jun 01
- A Phase 2 Study of ASONEP™ to Treat Unresectable and Refractory Renal Cell Carcinoma Start of enrollment: 2013 Feb 01
- Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance Start of enrollment: 2019 Feb 28
Publications & Presentations
PubMed
- 30 citationsACE2 abrogates tumor resistance to VEGFR inhibitors suggesting angiotensin-(1-7) as a therapy for clear cell renal cell carcinoma.Prateek Khanna, Hong Jie Soh, Chun-Hau Chen, Ruchi Saxena, Seema Amin
Science Translational Medicine. 2021-01-20 - 12 citationsStudy of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts.Chun-Hau Chen, Swati S. Bhasin, Prateek Khanna, Joshi M, Joslin Pm
Oncogenesis. 2019-02-22 - 11 citationsAngiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell CarcinomaWenxin Xu, Maneka Puligandla, Judith Manola, Andrea J. Bullock, Daniel Tamasauskas
Clinical Cancer Research. 2019-10-15
Journal Articles
- Study of Cathepsin B Inhibition in VEGFR TKI Treated Human Renal Cell Carcinoma XenograftsDavid A Frank, Rupal S Bhatt, Seth L Alper, Prateek Khanna, Nature
Press Mentions
Promising Triple Therapy Approach Identified for Renal Cell CarcinomaJanuary 21st, 2021
Beth Israel Deaconess Medical Center Expert Sources Available for Prostate Health MonthAugust 23rd, 2019
Blood Test Could Detect Kidney Cancer up to Five Years Prior to Clinical DiagnosisAugust 16th, 2018- Join now to see all
Grant Support
- Mechanism Of Acquired Resistance To VEGF-R Antagonists In RCCNational Cancer Institute2010–2011
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
